NCT02236403View on ClinicalTrials.gov

Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1%

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Chronic Blepharitis
Interventions
DRUG

Ivermectin 0.1% Metronidazole 1%

OTHER

None intervention

Volunteers with no signs of blepharitis and with eyelashes with no demodex. Symptoms and signs will be compared with experimental group

Trial Locations (1)

Unknown

Hospital de Engativa, Bogotá

All Listed Sponsors
lead

Universidad Nacional de Colombia

OTHER

NCT02236403 - Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% | Biotech Hunter | Biotech Hunter